ETHZilla Corporation is a clinical-stage biotechnology firm based in Palm Beach, Florida, focused on developing innovative therapeutics for chronic pain, inflammation, fibrosis, and various inflammatory diseases. The company is dedicated to addressing significant unmet medical needs through its advanced pipeline of novel drug candidates, which promise to enhance patient outcomes in underserved therapeutic areas. With a strong commitment to research and development, ETHZilla aims to leverage cutting-edge science to deliver transformative solutions that can reshape treatment paradigms in these critical health domains.